SELLAS Life Sciences Group, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
SLS Nasdaq 2836 sellaslifesciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for SELLAS Life Sciences Group, Inc.

Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive - Aug 4th, 2026 11:17 pm
SELLAS Life Sciences Group (SLS) Is Up 11.2% After Daiwa Boosts Stake And REGAL Nears Readout - Has The Bull Case Changed? - Aug 4th, 2026 3:08 pm
SELLAS Life Sciences Group (SLS) Nears REGAL Analysis, Is The Stock Too Expensive? - Aug 4th, 2026 9:13 am
SELLAS Life Sciences Group (SLS) Stock Looks Priced At A Premium - Aug 4th, 2026 7:13 am
SLS Stock Logs Best Day In Over 2 Weeks: Citigroup Builds Nearly $5M Stake Ahead Of Key AML Trial Trigger - Aug 3rd, 2026 7:29 pm
SLS Stock Eyes Green Start To August After Nearly $6M In Fresh Institutional Buying: Retail Stays Bearish - Aug 3rd, 2026 2:46 am
SLS Stock In Spotlight After Vanguard Capital Discloses 5.19% Stake – Retail Calls It ‘Huge Vote Of Conviction’ As AML Trial Readout Nears - Jul 31st, 2026 10:32 am
SLS Stock Turns Green After 3-Day Rout: Five Investors Add Shares As Key AML Trial Nears Final Trigger - Jul 30th, 2026 12:53 am
SLS Stock Heads For Worst Month In Over 2 Years — But Retail Bulls ‘Hold’ For AML Readout And Buyout Hopes - Jul 28th, 2026 9:33 pm
SLS Stock Hits 1-Month Low On China Arbitration Blow — Retail Bulls Call It A ‘Nothingburger’ Ahead Of AML Readout - Jul 27th, 2026 11:06 pm
SLS Stock Climbs Premarket: Here’s What Smart Money Is Doing As Sellas Nears Critical Phase 3 AML Readout - Jul 27th, 2026 2:17 am
Sellas CEO Angelos Stergiou Says ‘100% Certain’ AI Can Be Used To Beat Cancer - Jul 24th, 2026 7:44 am
SLS Stock Rises Overnight: Retail Traders Call New AML Survival Data 'Huge' Ahead Of CEO’s Fox Appearance - Jul 23rd, 2026 11:11 pm
SLS Stock July Rout Deepens: ‘Pharma Bro’ Martin Shkreli Questions Timing Of AML Trial, Says Data May Wait Until Christmas - Jul 23rd, 2026 12:27 am
SLS Stock Tracks Worst Month Since March: Investor Slashes Stake By Over 30% As Quiet Period Begins Ahead Of AML Readout - Jul 21st, 2026 8:18 pm
SLS Stock Rises Overnight: Retail Thinks CEO Just Dropped Buyout Clues Ahead Of Fox Appearance - Jul 20th, 2026 10:08 pm
SLS Stock Jumps Ahead Of CEO’s Fox Appearance: Retail Bets AML Readout Could Spark Big Pharma Bidding War - Jul 19th, 2026 9:00 pm
Will Near-Complete REGAL Phase 3 GPS Data and New Executive Terms Change SELLAS Life Sciences Group's (SLS) Narrative - Jul 18th, 2026 3:08 pm
SELLAS Life Sciences Group (SLS) Stock Looks Rich On Book Value Yet Strong On Returns - Jul 18th, 2026 2:08 am
SELLAS Life Sciences Group (SLS) Stock Pricey Following Phase 3 Trial Buzz - Jul 18th, 2026 12:09 am